Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

591 ARTÍCULOS , VIENDO DEL 106 AL 120

Changes in Daily Functioning in Association With Tau and Amyloid Among Unimpaired Older Adults With and Without Elevated Amyloid

Dubbelman MA, Liu A, Donohue MC, Langford O, Raman R, Rentz DM, Amariglio R, Sperling RA, Aisen PS, Marshall GA; as the A4 Study team.

Neurology. 2025 Jun 24;104(12):e213775. doi: 10.1212/WNL.0000000000213775. Epub 2025 May 29.

Optimizing exercise dosage for executive function in alzheimer's disease: A Bayesian dose-response meta-analysis of randomized trials

Sui S, Wang M.

Arch Gerontol Geriatr. 2025 Dec;139:106001. doi: 10.1016/j.archger.2025.106001. Epub 2025 Aug 25.

Independent effects of white matter lesion volume and APOE ɛ4 on ARIA-H in A4 Study

Shirzadi Z, Schultz AP, Loghmani N, Yang HS, Ford J, Yaari R, Properzi M, Yau WW, Liu L, Rafii MS, Donohue MC, Brickman AM, Jack CR Jr, Greenberg SM, Aisen P, Sperling RA, Chhatwal JP; A4 Study Team.

Alzheimers Dement. 2025 Oct;21(10):e70751. doi: 10.1002/alz.70751.

Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis

Boongird C, Anothaisintawee T, Tearneukit W, Wongpipathpong W, Suthutvoravut U, Thongpan M, Pongsettakul N, Attia J, McKay GJ, Rattanasiri S, Thakkinstian A.

J Alzheimers Dis. 2025 Nov;108(2):509-521. doi: 10.1177/13872877251378354. Epub 2025 Oct 3.

Effect of combined and intensive rehabilitation on cognitive function in patients with Alzheimer's disease evaluated through a randomized controlled trial

Vostrý M, Chytrý V, Cmorej PC, Fleischmann O, Kubová N.

Sci Rep. 2025 Mar 8;15(1):8110. doi: 10.1038/s41598-025-93236-6.

Stage-Wise IoT Solutions for Alzheimer's Disease: A Systematic Review of Detection, Monitoring, and Assistive Technologies

Salvi S, Garg L, Gurupur V.

Sensors (Basel). 2025 Aug 23;25(17):5252. doi: 10.3390/s25175252.

Artificial intelligence-driven eye tracker models for Alzheimer's disease diagnosis: A systematic review and meta-analysis

Ketata I, Ellouz E.

J Alzheimers Dis. 2025 Dec;108(4):1488-1506. doi: 10.1177/13872877251389145. Epub 2025 Oct 24.

Effectiveness of virtual reality interventions on quality of life, cognitive function and physical function in older people with Alzheimer's disease: A systematic review

Vásquez-Carrasco E, Hernandez-Martinez J, Sepúlveda-Ramírez M, Carmine F, Sandoval C, Nobari H, Valdés-Badilla P.

Ageing Res Rev. 2025 Jul;109:102785. doi: 10.1016/j.arr.2025.102785. Epub 2025 May 26.

Artificial Intelligence for Alzheimer's disease diagnosis through T1-weighted MRI: A systematic review

Basanta-Torres S, Rivas-Fernández MÁ, Galdo-Alvarez S.

Comput Biol Med. 2025 Oct;197(Pt A):111028. doi: 10.1016/j.compbiomed.2025.111028. Epub 2025 Sep 5.

Natural Evolution and Heterogeneity of Neuropsychiatric Symptoms Across Neurocognitive Disorders: A Systematic Review and Meta-Analysis of Longitudinal Studies

Skoda O, Conant M, Couture V, Bruneau MA, Forget MF, Nguyen QD, Desmarais P.

Int J Geriatr Psychiatry. 2025 Oct;40(10):e70169. doi: 10.1002/gps.70169.

Lower baseline amyloid beta burden is associated with greater percent of amyloid beta positron emission tomography reduction and better clinical outcomes in the aducanumab Phase 3 trials ENGAGE and EMERGE in early Alzheimer's disease

Burton J, Brothers HM, Hutchison RM, Murphy J, Sun T, Dent G, Curiale G, Kowalski K.

J Prev Alzheimers Dis. 2025 Aug;12(7):100202. doi: 10.1016/j.tjpad.2025.100202. Epub 2025 May 24.

Mobile Telehealth Intervention to Support Care Partners of Patients With Alzheimer Disease and Related Dementias (I-CARE 2): Protocol for a Randomized Effectiveness Clinical Trial

Hill JR, Gardner B, Rodriguez MJ, Golzarri-Arroyo L, Zoh RS, Boustani Z, Burnell J, Jordan EJ, Boustani MA, Holden RJ.

JMIR Res Protoc. 2025 Sep 3;14:e73387. doi: 10.2196/73387.

Hypometabolic subtypes of AD are linked to comorbid hippocampal sclerosis and Lewy body pathology

Levin F, Dyrba M, Teipel SJ, Grothe MJ.

Alzheimers Res Ther. 2025 Jul 25;17(1):172. doi: 10.1186/s13195-025-01796-6.

Fornix Mediates Information Propagation in Brain Networks Following DLPFC-Targeted rTMS in Alzheimer's Disease: A Randomized Controlled Trial

Shao Y, Liu L, Zhu S, Zhu Z, Wang P, Biswal BB, Lin H.

CNS Neurosci Ther. 2025 Nov;31(11):e70630. doi: 10.1111/cns.70630.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias